ITAC Assessment: SF0046
ITAC logo
ITAC Assessment: SF0046
Grant Funding Opportunity NOW OPEN
Up to $300k at 50% cost share for qualifying* projects.
Grant Funding Opportunity Open
Qualifying* small and medium-sized US manufacturers, that received an ITAC, Onsite Energy/CHP TAP, or qualified equivalent assessment since 2018 can now apply for grants for implementation of assessment recommendations at up to 50% of qualifying* project costs with a maximum of $300,000 per grant.
IMPORTANT: The grant program now operates on a rolling basis and applications may be submitted at any time through the year, with quarterly reviews.
*See Full Grant Solicitation for full qualification and selection details.
Assessment Year 1995
Principal Product Ophthalmic Pharmaceuticals
NAICS
n/a
SIC 3845: Electromedical and Electrotherapeutic Apparatus
Sales Range $1
M
to 5
M
# of Employees 80
Plant Area 19,869
ft2
Annual Production 250,000
units
Production Hrs. Annual 2,000
hrs
Location (State) California

Facility Energy Cost and Usage

Source Yearly Cost Usage
Electricity Usage $104,600 1,123,388
kWh
Natural Gas $38,204 6,706
MMBtu
TOTAL YEARLY COSTS -
RECOMMENDED SAVINGS* $4,110 *Non-energy impacts included in savings.
IMPLEMENTED SAVINGS* $3,425

Recommendations

# Description Yearly Savings* Imp'd Cost* Status Electricity Usage Savings
01 2.7142: Utilize higher efficiency lamps and/or ballasts $3,425 $11,089 $3,425
36,635
kWh
02 2.7135: Install occupancy sensors $474 $1,244 $474
4,982
kWh
03 2.4111: Utilize energy-efficient belts and other improved mechanisms $211 $914 $211
2,345
kWh
TOTAL RECOMMENDED $4,110 $13,247 $4,110
43,962
kWh
TOTAL IMPLEMENTED $3,425 $11,089 $3,425
36,635
kWh
*Savings and costs are best estimates based on the center's site visit, associated engineering analysis, and typical capital and labor costs